Picture of Beximco Pharmaceuticals logo

BXP Beximco Pharmaceuticals Balance Sheet

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Annual balance sheet for Beximco Pharmaceuticals, fiscal year end - June 30th, BDT millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
BAS
BAS
BAS
BAS
BAS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments9346356751,1691,136
Net Total Accounts Receivable
Net Total Receivables3,7063,7533,3883,9964,379
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets13,26413,04913,77118,41920,876
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment34,05735,24136,53142,37942,808
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets49,21450,11952,24666,14869,157
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities12,74611,3589,35012,73613,265
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities19,62617,62415,21625,54825,476
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity29,58832,49537,03140,60043,681
Total Liabilities & Shareholders' Equity49,21450,11952,24666,14869,157
Total Common Shares Outstanding